Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Minneapolis, Minnesota
- Most recent report
- 8-K, filed Aug 26, 2026
- Incorporated
- Delaware
- Filings on record
- 535 filings
- On EDGAR
- CIK 1603454
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 39
News 8 of 90
Prospectuses and Registrations 8 of 44
- 424B5 Prospectus supplement for an offering Jun 5, 2026
- FWP Free writing prospectus Jun 4, 2026
- 424B5 Prospectus supplement for an offering Jun 3, 2026
- S-8 Registration statement for an employee plan May 18, 2026
- S-3ASR Automatic shelf registration Jan 9, 2026
- 424B5 Prospectus supplement for an offering Jul 31, 2025
- 424B5 Prospectus supplement for an offering Jul 31, 2025
- FWP Free writing prospectus Jul 30, 2025
Proxies 8 of 25
- DEFA14A Extra proxy material Apr 2, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 2, 2026
- DEFA14A Extra proxy material Apr 1, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2025
- DEFA14A Extra proxy material Aug 28, 2024
- DEF 14A Proxy statement for a shareholder vote Aug 28, 2024
- PRE 14A Preliminary proxy statement Aug 16, 2024
- DEFA14A Extra proxy material Mar 28, 2024
Ownership 8 of 266
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 11, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 16, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 16, 2026
- 4 Insider reported a trade Jul 16, 2026
- 144 Notice of a proposed sale of restricted stock Jul 14, 2026
Other 8 of 71
Everything here comes from Celcuity Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.